Schedule 13D ownership disclosure

Boston Therapeutics, Inc.

Security class unavailable · CUSIP: 05351T100

Event date: 2016-08-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-16-007615
Form type
SC 13D/A
Filer
NANOMIX Corp
CIK
CIK 1473579
Filed
Oct 13, 2016
Reporting period
Aug 12, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub